Biomarkers for PD How can we approach complexity?

被引:2
|
作者
Berg, Daniela [1 ]
Bandmann, Oliver [2 ]
机构
[1] Univ Tubingen, Dept Neurodegenerat, Tubingen, Germany
[2] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England
关键词
PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; RISK; MUTATION;
D O I
10.1212/WNL.0b013e3182825184
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:608 / 609
页数:2
相关论文
共 50 条
  • [1] How can we improve adherence?
    Price, Patricia
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 : 201 - 205
  • [2] HOW CAN BIOMARKERS HELP IN CHILDREN WITH CF?
    Sagel, Scott D.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 139 - 141
  • [3] Antibiotic stewardship: Why we must, how we can
    Srinivasan, Arjun
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 (09) : 673 - 679
  • [4] HOW CAN WE BE MORAL WHEN WE ARE SO IRRATIONAL?
    Sahlin, Nils-Eric
    Brannmark, Johan
    LOGIQUE ET ANALYSE, 2013, (221) : 101 - 126
  • [5] How should we be using biomarkers in trials of disease modification in Parkinson's disease?
    Vijiaratnam, Nirosen
    Foltynie, Thomas
    BRAIN, 2023, 146 (12) : 4845 - 4869
  • [6] Communication between anaesthesiologists and patients: how are we doing it now and how can we improve?
    Hool, Alison
    Smith, Andrew F.
    CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (03) : 431 - 435
  • [7] How we approach hemangiomas in infants
    Mayer, Jennifer L. R.
    Intzes, Stefanos
    Oza, Vikash S.
    Blei, Francine
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [8] Guess What We Can Hear-Novel Voice Biomarkers for the Remote Detection of Disease
    Sara, Jaskanwal Deep Singh
    Orbelo, Diana
    Maor, Elad
    Lerman, Lilach O.
    Lerman, Amir
    MAYO CLINIC PROCEEDINGS, 2023, 98 (09) : 1353 - 1375
  • [9] How Can We Resolve Lewontin's Paradox?
    Charlesworth, Brian
    Jensen, Jeffrey D.
    GENOME BIOLOGY AND EVOLUTION, 2022, 14 (07):
  • [10] Oncology protocols: how can we do better?
    Kaste, Sue C.
    PEDIATRIC RADIOLOGY, 2011, 41 : S166 - S169